Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SH3 and PX domain-containing protein 2A (SH3PXD2A, also known as TKS5) is an intracellular adapter and scaffold protein containing five SH3 domains and a PX domain. It acts as an organizer protein required for the formation of dynamic actin-rich structures such as podosomes and invadopodia, which are involved in cell invasion and extracellular matrix degradation. SH3PXD2A is necessary for protease-driven invasion by cancer cells and plays a role in superoxide production via activation of NADPH oxidases. It also mediates some neurotoxic effects in association with amyloid-beta. This protein is highly expressed in invasive cancer cells and is involved in cell migration, invasion, and signaling pathways such as those regulated by Src-family kinases[1][2][4][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH3 and PX domain-containing protein 2A (SH3PXD2A).